Epstein-Barr virus load in rheumatoid arthritis patients and normal controls: accurate quantification using real time PCR

por Pieri-Balandraud, N, Reviron, D, Roudier, J, Roudier, C
Publicado 2002

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis

por Mugnier, B, Reviron, D, Darque, A, Balandraud, N, Roudier, C, Roudier, J
Publicado 2004

In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS)

por Guis, S, Nielsen, W, Boetsch, G, Dutour, O, Mercier, P, Reviron, D, Roudier, J
Publicado 2001

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors

por Balandraud, N, Meynard, JB, Auger, I, Sovran, H, Mugnier, B, Reviron, D, Roudier, J, Roudier, C
Publicado 2004

Epstein–Barr virus load is higher in rheumatoid arthritis patients than in normal controls

por Pieri-Balandraud, N, Baptiste Meynard, J, Auger, I, Sovran, H, Mugnier, B, Reviron, D, Roudier, J, Roudier, C
Publicado 2003

The shared epitope revisited: shared epitope negative HLA-DR alleles influence susceptibility to rheumatoid arthritis

por Reviron, D, Perdriger, A, Toussirot, E, Wendling, D, Balandraud, N, Guis, S, Semana, G, Tiberghien, P, Mercier, P, Roudier, J
Publicado 2001

HLA DRB101 and macrophagic myofasciitis

por Guis, S, Pellissier, JF, Nicoli, F, Reviron, D, Mattei, JP, Gherardi, RK, Pelletier, J, Kaplanski, G, Figarella-Branger, D, Roudier, J
Publicado 2003